CAMBRIDGE, Mass — Akrivis Technologies, LLC announced today that it has reached a strategic alliance and distribution agreement with United States Biological Corporation, a world leader in the manufacture and distribution of antibodies and biochemicals used in research laboratories and production facilities. Adapting elements of nanotechnology with molecular detection and immunology, Akrivis Technologies has developed […]
Life Technologies (NASDAQ: LIFE) announced an exclusive agreement with Pathogenica, Boston, Massachusetts, to co-market and distribute for research use, the Pathogenica HAI (Hospital Acquired Infection) BioDetection Kit on the Ion Torrent PGM[ TM ] in Europe, the Middle East and Africa (EMEA). Based on Pathogenica’s DxSeq[ TM ] technologyand the Ion Torrent[ TM ] sequencing […]
CHATSWORTH, Calif., — IRIS International, Inc. (Nasdaq:IRIS), a leading manufacturer of automated in-vitro diagnostics systems and consumables, and a provider of high value personalized medicine solutions, today announced that it has entered into a definitive merger agreement under which Danaher Corporation (NYSE:DHR) will acquire IRIS International for $19.50 per share in cash, representing an approximate […]
INDIANAPOLIS, — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today the commercial availability of a new test to assess a patient’s viral load of cytomegalovirus (CMV). Physicians use information from the test to help them manage patients who have been diagnosed with CMV disease, specifically patients with an immune system that has been suppressed for […]
MOUNTAIN VIEW, Calif. and SHENZHEN, China,– Complete Genomics, Inc. (Nasdaq:GNOM) (“Complete”), an innovative leader in whole human genomic sequencing, and BGI-Shenzhen (“BGI”), a leading international genomics company based in Shenzhen, China, today announced that they have entered into a definitive merger agreement. Through this agreement, a wholly-owned U.S. subsidiary of BGI will launch a tender […]
CARLSBAD, Calif., — Life Technologies Corporation (NASDAQ:LIFE – News) today announced that the company has entered into a Master Development Agreement with Bristol-Myers Squibb Company (NYSE:BMY) for current and future companion diagnostics projects. The current agreement constitutes the second collaboration between the two companies and represents another step in Life Technologies’ strategy to develop its […]
Omaha, Neb.– Transgenomic, Inc. (OTC/BB: TBIO) today announced the appointment of Mark P. Colonnese as Executive Vice President and Chief Financial Officer of the Company. In this role, Mr. Colonnese will lead the Company’s financial and capital markets strategy, as well as advise on business development and transactional activities. Mr. Colonnese has nearly 30 years […]
BEJING, China, and HILDEN, Germany, — QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced an agreement with Lepu Medical Technology (Beijing) Co., Ltd., a leading medical device company in China, to provide QIAGEN’s ESEQuant Lateral Flow System for use in emergency rooms with Lepu’s tests for cardiac markers that diagnose acute myocardial infarction […]
MANSFIELD, Mass. — PrimeraDx, a molecular diagnostics company, announced today that the ICEPlex system, a quantitative multiplex PCR system, and their C. difficile detection assay both received the CE mark. “Obtaining the CE mark on our instrument and assay is an important step in the process of global commercialization of our extensive pipeline of molecular […]
SAN DIEGO & BOSTON — Illumina, Inc. (NASDAQ:ILMN) and Partners HealthCare today announced a strategic alliance to offer medical geneticists and pathologists infrastructure and networking tools to support the interpretation and reporting process for genetic sequencing data. The tools will integrate the functionality of Illumina’s MiSeq® sequencing system and Partners GeneInsight Suite®, an IT platform […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
